Donaldson (DCI) Q3 2026 earnings review
Diversification Pays Off as Mobile and Life Sciences Offset Industrial Weakness
Donaldson delivered a solid Q3 with sales up 5.8% YoY to $995.1M and adjusted EPS growing 7.1% to $1.06. The quarter's success was heavily reliant on the Mobile Solutions and Life Sciences segments, which masked a reversing trend in Industrial Solutions. While management highlighted a record adjusted operating margin of 16.6% for the quarter, the reality of ongoing gross margin pressure forced a slight reduction in full-year operating margin guidance. The closure of the $829M Facet acquisition provides a clear catalyst for future industrial growth, though it will be slightly dilutive to EPS in the immediate term.
🐂 Bull Case
Mobile Aftermarket sales accelerated to 8.1% growth, driven by double-digit increases in the independent channel, proving the 'razor-to-sell-razor-blades' model is working.
Life Sciences continues its double-digit growth streak (+12.7% in Q3), prompting management to aggressively raise the segment's full-year growth guidance.
🐻 Bear Case
Industrial Solutions contracted 0.6% YoY, driven by a sharp 13.5% drop in Aerospace & Defense due to supply chain constraints and project timing issues.
Adjusted gross margin compressed 10 bps YoY to 34.4%, constrained by ongoing operational inefficiencies in Power Generation production shifts.
⚖️ Verdict: 🟢
Bullish. The ability to raise the floor on full-year EPS and organic sales guidance despite weakness in the Industrial segment highlights the strength of Donaldson's diversified portfolio and disciplined cost controls.
Key Themes
Mobile Aftermarket Driving the Engine
Mobile Solutions growth accelerated to 8.1%, up from 1.7% in Q2. The Aftermarket sub-segment was the standout, growing 8.1% on the back of double-digit growth in the independent channel. This high-margin recurring revenue stream is buffering the company against cyclical choppiness in first-fit equipment sales.
Facet Acquisition Closed
The $829M all-cash acquisition of Facet closed on May 4. While it will cause ~$0.03 of EPS dilution in FY26 due to transaction amortization, it integrates high-margin, mission-critical fuel and fluid filtration into the Industrial Solutions segment. It is expected to contribute $25-$30M in sales in the final quarter of the year.
Tech Advancements in Disk Drive
Life Sciences sales accelerated nicely, driven by robust demand for Food & Beverage equipment and Disk Drive applications. The Disk Drive business continues to benefit from AI-driven data center capacity expansion and cloud storage needs, specifically leveraging new HAMR (Heat-Assisted Magnetic Recording) technology.
Macro Tailwinds in Mobile First-Fit
Off-Road sales grew 8.8% YoY, primarily due to improving end-market conditions in the Construction sector. On-Road sales grew 5.2%, supported by increased truck production in the EMEA region, indicating that first-fit cyclical weakness may be slowly bottoming out.
Aerospace & Defense Hits a Wall
The A&D sub-segment reversed violently, shrinking 13.5% YoY. Management pointed to weaker new equipment sales, project timing, and ongoing supply chain constraints. This directly contradicts the broader narrative of an Industrial 'super cycle' and suggests execution or supplier risk is capping upside.
Margin Narrative Contradicted by Guidance
Management touted an 'all-time high adjusted operating margin' of 16.6% in Q3. However, this was entirely driven by slashing operating expenses (down to 17.8% of sales). Adjusted gross margin actually fell 10 bps to 34.4% due to production shift inefficiencies in Power Generation. Tellingly, management lowered full-year adjusted operating margin guidance from 16.0-16.4% down to 15.8-16.2%, indicating that near-term gross margin pressure is heavier than the Q3 operating beat suggests.
Industrial Filtration Solutions (IFS) Volume Stagnation
While IFS revenue grew 2.3%, management noted this was driven by net pricing benefits and Power Generation equipment sales, which were 'partially offset by volume declines in Industrial Gases and dust collection.' Flat or negative volumes in core industrial areas indicate customers are still delaying Capex decisions.
Other KPIs
Increased from 22.1% a year ago due to a decrease in discrete tax benefits. This served as a slight headwind to bottom-line EPS growth.
Adjusted YTD cash conversion improved significantly to 72.3% from 59.8% in the prior year period. Full-year conversion guidance remains at a healthy 85% to 95%, supporting the $104M paid in dividends and $108.5M in share repurchases year-to-date.
Guidance
Accelerating. The floor was raised from the prior expectation of +1% to +5%, reflecting confidence in the Mobile and Life Sciences segments to outpace Industrial sluggishness.
Stable. The range was narrowed and implies a 7% to 9% increase over FY25 adjusted EPS of $3.68. This excludes the ~$0.03 dilution expected from the Facet acquisition.
Decelerating. This metric was quietly lowered from previous expectations of 16.0% to 16.4%. It shows that while OpEx is under control, gross margin inefficiencies (like Power Generation footprint moves) are taking a toll on the full-year picture.
Accelerating. Upgraded significantly from the prior 5% to 9% outlook, cementing this segment as the company's most consistent high-growth engine.
Key Questions
Power Generation Inefficiencies
You noted operating inefficiencies related to production shifts in Power Generation impacting gross margins. What is the precise timeline for these shifts to be completed, and when will they flip from a margin drag to a margin tailwind?
Aerospace & Defense Visibility
A&D sales fell 13.5% due to project timing and supply chain constraints. Are these orders secured in the backlog and merely shifting to the right, or is there a risk of customer cancellation if supply chain issues persist?
Facet Integration and Synergies
With the Facet acquisition closed, you are modeling short-term EPS dilution. What are the key operational milestones over the next 12 months required to make this deal accretive, and are there meaningful cost synergies to be extracted?